References
- Rademaker-LakhaiJMCrulMZuurLRelationship between cisplatin administration and the development of ototoxicityJ Clin Oncol200624691892416484702
- ManoharSLeungNCisplatin nephrotoxicity: a review of the literatureJ Nephrol2018311152528382507
- GreggRWMolepoJMMonpetitVJCisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicityJ Clin Oncol19921057958031569451
- MarshakTSteinerMKaminerMLevyLShupakAPrevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled studyOtolaryngol Head Neck Surg2014150698399024618499
- Al-NouryKDistortion product otoacoustic emission for the screening of cochlear damage in children treated with cisplatinLaryngoscope201112151081108421495043
- XieJTalaskaAESchachtJNew developments in aminoglycoside therapy and ototoxicityHear Res20112811–2283721640178
- GuthrieOWAminoglycoside induced ototoxicityToxicology20082492–3919618514377
- HazlittRAMinJZuoJProgress in the development of preventative drugs for cisplatin-induced hearing lossJ Med Chem201861135512552429361217
- LeitnerMGHalaszovichCROliverDAminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphateMol Pharmacol2011791516020935082
- CallejoASedó-CabezónLJuanIDLlorensJCisplatin-induced ototoxicity: effects, mechanisms and protection strategiesToxics20153326829329051464
- LibermanMCGaoJHeDZWuXJiaSZuoJPrestin is required for electromotility of the outer hair cell and for the cochlear amplifierNature2002419690430030412239568
- DallosPWuXCheathamMAPrestin-based outer hair cell motility is necessary for mammalian cochlear amplificationNeuron200858333333918466744
- DallosPFaklerBPrestinFBPrestin, a new type of motor proteinNat Rev Mol Cell Biol20023210411111836512
- SurovtsevaEVJohnstonAHZhangWPrestin binding peptides as ligands for targeted polymersome mediated drug delivery to outer hair cells in the inner earInt J Pharm20124241–212112722227343
- HaakeSMDinhCTChenSEshraghiAAvan de WaterTRDexamethasone protects auditory hair cells against TNFα-initiated apoptosis via activation of PI3K/Akt and NFκB signalingHear Res20092551–2223219442713
- PalmerRMBridgeLFoxwellNAMoncadaSThe role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoidsBr J Pharmacol1992105111121596673
- ÖzelHEÖzdoğanFGürgenSGEsenEGençSSelçukAComparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicityJ Laryngol Otol2016130322523426830667
- YoumIWestMBLiWduXEwertDLKopkeRDsiRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicityInt J Pharm20175281–261162328627458
- YoonJYYangKJKimDEIntratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner earBiomaterials20157324325326414408
- AgrahariVAgrahariVMitraAKNanocarrier fabrication and macromolecule drug delivery: challenges and opportunitiesTher Deliv20167425727827010987
- KalinecGTheinPParkCKalinecFHEI-OC1 cells as a model for investigating drug cytotoxicityHear Res201633510511726930622
- OlivierJCHuertasRLeeHJCalonFPardridgeWMSynthesis of pegylated immunonanoparticlesPharm Res20021981137114312240939
- SunCWangXZhengZA single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administrationInt J Nanomedicine2015103567337925999718
- FernandezRHarrop-JonesAWangXDellamaryLLebelCPiuFThe sustained-exposure dexamethasone formulation OTO-104 offers effective protection against cisplatin-induced hearing lossAudiol Neurootol2016211222926789647
- Martín-SaldañaSPalao-SuayRAguilarMRRamírez-CamachoRSan RománJPolymeric nanoparticles loaded with dexamethasone or α-tocopheryl succinate to prevent cisplatin-induced ototoxicityActa Biomater20175319921028213099
- LinLMColbyGPBenderMTUse of the 0.027-inch VIA micro-catheter for delivery of Pipeline Flex: a technical noteJ Neurointerv Surg20179768969328151413
- WenXDingSCaiHNanomedicine strategy for optimizing delivery to outer hair cells by surface-modified poly(lactic/glycolic acid) nanoparticles with hydrophilic moleculesInt J Nanomedicine2016115959596927877041
- KimDKParkSNParkKHDevelopment of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticlesDrug Deliv201522336737424447111
- OswaldMGeisslerSGoepferichADetermination of the activity of maleimide-functionalized phospholipids during preparation of liposomesInt J Pharm201651419310227863688
- FengLWuHMaPMumperRJBenhabbourSRDevelopment and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivoInt J Nanomedicine201162545255622072889
- RybakLPMukherjeaDJajooSRamkumarVCisplatin ototoxicity and protection: clinical and experimental studiesTohoku J Exp Med2009219317718619851045
- ChirtesFAlbuSPrevention and restoration of hearing loss associated with the use of cisplatinBiomed Res Int2014201492548525140325
- Abi-HachemRNZineAvan de WaterTRThe injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategiesRecent Pat CNS Drug Discov20105214716320167005